MSH2 and breast carcinoma: Transcriptomic data were available for 1176 of the 3667 breast cancer samples (including 6 MLH1-altered, 5 MSH2-altered, 6 MSH6-altered, 5 PMS2-altered, and 1058 MMR-wt cases).